Jen-Tsung Chen Selected Research

Jen-Tsung Chen Research Topics

3	Neoplasms (Cancer) 01/2023 - 01/2022
2	Infections 09/2022 - 01/2022
2	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2021 - 01/2021
2	Tetraploidy 11/2018 - 11/2017
1	Virus Diseases (Viral Diseases) 09/2022
1	Hypoxia (Hypoxemia) 09/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Hyperglycemia 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	COVID-19 11/2020
1	Dehydration (Water Stress) 10/2020
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2020
1	Polyploidy 01/2020
1	Malnutrition (Nutritional Deficiencies) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2019

3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2021
2	GinsenosidesIBA 09/2022 - 01/2020
2	FlavonoidsIBA 01/2022 - 11/2017
2	PhytochemicalsIBA 01/2022 - 11/2020
2	diazonaphthalenedisulfonic acid (NDS)IBA 01/2020 - 11/2019
1	AntioxidantsIBA 01/2023
1	ginsenoside Rb1IBA 09/2022
1	Plant Growth Regulators (Plant Hormones)IBA 09/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA 01/2022
1	ResveratrolIBA 01/2022
1	LycopeneIBA 01/2022
1	Amylases FDA Link 01/2022
1	CarbohydratesIBA 01/2022
1	CurcuminIBA 01/2022
1	EnzymesIBA 01/2022
1	GlucosidasesIBA 01/2022
1	InterleukinsIBA 01/2022
1	Plant ExtractsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Starch (Cornstarch)IBA 01/2022
1	Sucrose (Saccharose)IBA 01/2022
1	TeaIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	IsothiocyanatesIBA 01/2022
1	GenisteinIBA 01/2022
1	CaspasesIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	CateninsIBA 01/2022
1	ElementsIBA 10/2020
1	SulfurIBA 10/2020
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 10/2020
1	MicronutrientsIBA 01/2020
1	SuspensionsIBA 01/2020
1	Colchicine FDA LinkGeneric 11/2018
1	thidiazuron (DROPP)IBA 11/2018
1	gastrodinIBA 11/2017

4	Therapeutics 09/2022 - 01/2021
1	Immunotherapy 01/2022